Home > Analytics > ZYDUS LIFESCIENCES

ZYDUS LIFESCIENCES
Intrinsic Value | Fundamental Analysis

BOM : 532321     NSE : ZYDUSLIFE    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : NA
Jul 26,2024
Price(EOD): ₹ 1,206.25
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 121,372.88 Cr
Value of ₹ 1 Lac invested in ZYDUS LIFESCIENCES
on Jul 26,2019 (price: ₹ 234.05)

₹ 1 L

₹ 5.15 L

1W : 4.5% 1M : 13.1% 1Y : 96.6%
COMMUNITY POLL
for ZYDUS LIFESCIENCES
Please provide your vote to see the results
ZYDUS LIFESCIENCES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
Industry Peers & Returns1W1M1Y
ZYDUS LIFESCIENCES 4.5% 13.1% 96.6%
SUN PHARMACEUTICAL INDUSTRIES 7.9% 12.6% 51.7%
CIPLA 5.9% 6.7% 43%
DR REDDYS LABORATORIES 1.8% 13.6% 29.6%
DIVIS LABORATORIES 5.7% 5.5% 23.4%
MANKIND PHARMA -2.5% -3.8% 12.9%
TORRENT PHARMACEUTICALS 5.4% 14.3% 59.2%
LUPIN 1.9% 16.1% 92.7%
AUROBINDO PHARMA 3.1% 15.5% 74.8%

FUNDAMENTAL ANALYSIS OF ZYDUS LIFESCIENCES

 
Fundamentals Score
[ Q(TTM): Mar2024, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 ZYDUSLIFE is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF ZYDUS LIFESCIENCES

 
Valuation Score
[As on : Jul 26,2024 ]

Ratio Consolidated
P/E
P/B
P/S
31.68
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 3,831.40 Cr
[Latest Qtr - Mar2024 - Consolidated Results ]

6.12
P/B Calculated based on Book Value of Rs 19,829.50 Cr
[Latest Year - Mar2024 - Consolidated Results ]

6.21
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 19,547.40 Cr
[Latest Qtr - Mar2024 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 10% undervalued companies ! Discover More →

FAIR VALUE OF ZYDUS LIFESCIENCES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
135%
84%
101%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF ZYDUS LIFESCIENCES


Insights 💡 ZYDUSLIFE is one of the top 40% companies with bullish price momentum currently! Discover More →

ZYDUS LIFESCIENCES vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF ZYDUS LIFESCIENCES

Year Debt/Equity ratio
Standalone Consolidated
2024
2023
2022
Avg_3yrs
0.39
0.35
0.2
0.31
0.04
0.07
0.25
0.12
[Last Annual Data : Mar2024]
Financial Ratios →

PLEDGED PROMOTER SHARES OF ZYDUS LIFESCIENCES

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF ZYDUS LIFESCIENCES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
22.83%
50.23%
67.15%
72.24%
10.44%
29.44%
218.44%
251.64%
QtrlyTrend
8
Latest Qtr: Mar2024
Quarterly Result Analysis →


ZYDUS LIFESCIENCES related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 5.3% 9.4% 50.2%
S&P BSE DIVIDEND STABILITY 3.3% 7.1% 60.1%
S&P BSE 150 MIDCAP 3.1% 4.2% 58.6%
S&P BSE MOMENTUM 3.1% 5.9% 77.9%
S&P BSE 400 MIDSMALLCAP 3.1% 3.9% 57.2%
NSE Indices1W1M1Y
NIFTY PHARMA 5.8% 10.6% 51.1%
NIFTY HEALTHCARE 5.7% 10.4% 48.4%
NIFTY200 MOMENTUM 30 INDEX 4.2% 2% 66.6%
NIFTY NEXT 50 2.9% 2.9% 65.5%
NIFTY ALPHA LOW-VOLATILTY 30 2.8% 6.4% 51.1%

You may also like the below Video Courses


FAQ about ZYDUS LIFESCIENCES


Is ZYDUS LIFESCIENCES good for long term investment?

As on Jul 26,2024, the Fundamentals of ZYDUS LIFESCIENCES look Strong and hence it may be good for long term investment! See Financial Performance of ZYDUS LIFESCIENCES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is ZYDUS LIFESCIENCES UnderValued or OverValued?

As on Jul 26,2024, ZYDUS LIFESCIENCES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of ZYDUS LIFESCIENCES ?

As on Jul 26,2024, the Intrinsic Value of ZYDUS LIFESCIENCES is Rs. 599.26 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 514.11
Fair Value [Median EV / Sales Model] : Rs. 654.79
Fair Value [Median Price / Sales Model] : Rs. 599.26
Estimated Median Fair Value of ZYDUS LIFESCIENCES : Rs. 599.26

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is ZYDUS LIFESCIENCES trading at a Premium or Discount?

As on Jul 26,2024, ZYDUS LIFESCIENCES is trading at a Premium of 101% based on the estimates of Median Intrinsic Value!